ออฟไลน์ด้วยแอป Player FM !
พอดคาสต์ที่ควรค่าแก่การฟัง
สปอนเซอร์
AMPLIA THERAPEUTICS LTD (ATX) - Pioneering Cancer Treatment: CEO & MD, Dr. Chris Burns on FAK Inhibitors, Pancreatic Cancer Breakthroughs, and the ACCENT Trial's Promise
Manage episode 445494735 series 3570035
Get ready to explore the cutting-edge world of cancer treatment with Dr. Chris Burns, CEO & MD of Amplia Therapeutics Limited and co-recipient of the 2024 Prime Minister's Prize for Innovation. Our latest episode of ASX Briefs takes you inside Amplia's groundbreaking work with Focal Adhesion Kinase (FAK) inhibitors, specifically their promising small molecule inhibitor, designed to tackle pancreatic cancer head-on. Dr. Burns shares the significant milestones in their ACCENT trial, including the recruitment of the first 26 patients and the remarkable achievement of six confirmed partial responses, which may signal a new frontier in cancer therapy.
Join us as Dr. Burns uncovers the science behind Amplia's innovative approach and how their treatment aims to enhance the effectiveness of existing therapies. He discusses the trial's progress, the potential for improved patient outcomes, and the exciting path forward with further recruitment underway. This episode is a compelling listen for anyone passionate about the future of oncology and the relentless pursuit of breakthroughs in cancer treatment. Don't miss the chance to hear firsthand from a leader at the forefront of medical innovation.
91 ตอน
Manage episode 445494735 series 3570035
Get ready to explore the cutting-edge world of cancer treatment with Dr. Chris Burns, CEO & MD of Amplia Therapeutics Limited and co-recipient of the 2024 Prime Minister's Prize for Innovation. Our latest episode of ASX Briefs takes you inside Amplia's groundbreaking work with Focal Adhesion Kinase (FAK) inhibitors, specifically their promising small molecule inhibitor, designed to tackle pancreatic cancer head-on. Dr. Burns shares the significant milestones in their ACCENT trial, including the recruitment of the first 26 patients and the remarkable achievement of six confirmed partial responses, which may signal a new frontier in cancer therapy.
Join us as Dr. Burns uncovers the science behind Amplia's innovative approach and how their treatment aims to enhance the effectiveness of existing therapies. He discusses the trial's progress, the potential for improved patient outcomes, and the exciting path forward with further recruitment underway. This episode is a compelling listen for anyone passionate about the future of oncology and the relentless pursuit of breakthroughs in cancer treatment. Don't miss the chance to hear firsthand from a leader at the forefront of medical innovation.
91 ตอน
모든 에피소드
×1 AGRIMIN LIMITED (AMN) - Transforming Global Food Security: CEO & Managing Director Debbie Morrow on Mackay Potash Project Breakthroughs, Strategic Export Growth, and Socio-Economic Development in… 10:27
1 MAGNETIC RESOURCES NL (MAU) - Uncovering Gold Mining Secrets: Managing Director George Sakalidis on Laverton Project Success, Strategic Partnerships, and Future Exploration Plans 7:16
1 HAZER GROUP LIMITED (HZR) - Revolutionizing Decarbonization: CEO Glenn Corrie on Methane Pyrolysis Innovation, Strategic Growth, and the Future of Clean Hydrogen Production 18:01
1 VIRIDIS MINING AND MINERALS (VMM) - Transforming Rare Earth Supply Chains: CEO Rafael Moreno on Colossus Project Breakthroughs, Strategic Partnerships, and Sustainable Innovations in South America 9:49
1 CLEVER CULTURE SYSTEMS LTD (CC5) - Revolutionizing Microbiology Laboratories: CEO Brent Barnes on AI-Driven Innovations, Strategic Rebranding, and Global Market Impact 8:49
1 DEXUS CONVENIENCE RETAIL REIT (DXC) - Transforming Real Estate Investment: Fund Manager Jason Weate on Strategic Asset Portfolio, Innovative Capital Recycling, and Future Growth in Australia 13:06
1 RED SKY ENERGY LIMITED (ROG) - Transforming Oil & Gas Business: Managing Director Andrew Knox on Strategic Asset Development, Global Expansion, and Future Growth in Energy Efficiency 8:17
1 NOVA EYE MEDICAL (EYE) - Revolutionizing Glaucoma Treatment: Managing Director Tom Spurling on iTrack™ Innovation, Strategic Global Expansion, and Future Growth Plans 8:19
1 BURGUNDY DIAMOND MINES (BDM)- Revolutionizing the Diamond Industry: CEO Kim Truter on Ethical Sourcing, Strategic Ekati Operations, and the Future Market Outlook 11:23
1 WOTSO PROPERTY (WOT)- Transforming Flexible Workspaces: CEO Jessie Glew on Strategic Suburban Expansion, Revenue Milestones, and Innovative Office Solutions in Australia and New Zealand 7:53
1 WESTERN MINES GROUP (WMG) - Pioneering Nickel Exploration: Managing Director Dr. Caedmon Marriott on Mulga Tank Discoveries, Strategic Development, and Future Market Potential 13:30
1 IONDRIVE LIMITED (ION) - Revolutionizing Battery Recycling: CEO Dr. Ebbe Dommisse on Innovative Eco-Friendly Solutions, Strategic Partnerships, and Global Market Impact 9:24
1 CLEARVUE TECHNOLOGIES LTD (CPV) - Transforming Architecture with Solar Innovation: CEO Martin Deil on Building-Integrated Photovoltaics, Strategic Market Expansion, and the Path to Sustainable… 9:24
1 IR DEPARTMENT - Transforming Investor Relations: Founder & Managing Director Jane Lowe on Strategic AGMs, ESG Priorities, and Future Industry Trends 14:57
1 RESOURO STRATEGIC METALS LTD (RAU) - Revolutionizing Rare Earths: CEO Alistair Stephens on Tiros Project Breakthroughs, Brazilian Expansion, and Dual ASX Listing Strategy 6:08
ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ